|
ID
|
Phenotype
|
Genotype#
|
Forward typing
|
Reverse typing
|
|---|
|
Anti-A
|
Anti-B
|
Anti-AB
|
Anti-A1
|
Anti-H
|
Ac
|
Bc
|
Oc
|
|---|
|
1
|
Aw
|
ABO*A1.02/ABO*O.01.01 with c.28. + 1-2delGT
|
1 +
|
0
|
1 +
|
0
|
4 +
|
1 +
|
4 +
|
0
|
|
2
|
Bel
|
ABO*B.01/ABO*O.01.02 with c.28 + 5G > A
|
0
|
0
|
0
|
0
|
4 +
|
4 +
|
0
|
0
|
|
3
|
Bel
|
ABO*B.01/ABO*O.01.02 with c.28 + 5G > C
|
0
|
0
|
0
|
0
|
4 +
|
4 +
|
0
|
0
|
|
4
|
B3
|
ABO*B3.03/ABO*O.01.01
|
0
|
mf
|
2 +
|
0
|
3 +
|
2 +
|
0
|
0
|
|
5
|
AB3
|
ABO*A1.02/ABO*B3.03
|
4 +
|
1 + mf
|
4 +
|
4 +
|
3 +
|
0
|
0
|
0
|
|
6
|
AB3
|
ABO*A1.02/ABO*B3.03
|
4 +
|
3 + mf
|
4 +
|
3 +
|
4 +
|
0
|
0
|
0
|
|
7
|
Bel
|
ABO*B.01/ABO*O.01.02 with c.204-1G > A
|
0
|
0
|
0
|
0
|
4 +
|
4 +
|
1 +
|
0
|
|
8
|
Ael
|
ABO*AEL.new/ABO*O.01.02
|
0
|
0
|
0
|
0
|
4 +
|
±
|
3 +
|
0
|
|
9
|
Ael
|
ABO*AEL.new/ABO*O.01.01
|
0
|
0
|
0
|
0
|
4 +
|
1 +
|
4 +
|
0
|
- #ABO*B3.03 was ABO*B.01 with c.155 + 5G > A; ABO*AEL.new was ABO*A1.02 with c.374 + 5G > A. Ac A cells, Bc B cells, Oc O cells. 1 + to 4 + = agglutination of increasing strength; mf = mixed-field agglutination; 0 = no agglutination. Nucleotide position 1 is identical to the first nucleotide of the coding sequence
